A detailed history of Pfc Capital Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Pfc Capital Group, Inc. holds 6,250 shares of LLY stock, worth $4.68 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares
6,250
Previous 5,900 5.93%
Holding current value
$4.68 Million
Previous $5.34 Million 3.67%
% of portfolio
2.69%
Previous 2.69%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $270,249 - $336,007
350 Added 5.93%
6,250 $5.54 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $366,059 - $459,065
505 Added 9.36%
5,900 $5.34 Million
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $38,493 - $51,498
65 Added 1.22%
5,395 $4.2 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $2.8 Million - $3.3 Million
5,330 New
5,330 $3.11 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pfc Capital Group, Inc. Portfolio

Follow Pfc Capital Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfc Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pfc Capital Group, Inc. with notifications on news.